Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Risk of Non-infectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database

Tian Xia; Lucia Sobrin; Yinxi Yu; gayatri susarla; Weilin Chan; John H Kempen; Rebecca Hubbard; Brian L VanderBeek

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2053. doi:

ARVO Annual Meeting Abstract June 2020

Incidence of Cataract in Eyes with Anterior Uveitis

John H Kempen; George N. Papaliodis; Bernard Rosner; Kurt Dreger; Gui-Shuang Ying; C Stephen Foster; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2069. doi:

ARVO Annual Meeting Abstract June 2020

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Caroline Minkus; Maxwell Pistilli; Kurt Dreger; Tonetta Fitzgerald; Abhishek Payal; Hosne Begum; R Oktay Kacmaz; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt; C Stephen Foster; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2070. doi:

ARVO Annual Meeting Abstract July 2019

Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on initiating antitubercular therapy in presumed tubercular retinal vasculitis

Rupesh Vijay Agrawal; Ilaria Testi; Sarakshi Mahajan; Dhananjay Raje; Aniruddha Agarwal; Dinesh Gunasekeran; John H Kempen; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):861. doi:

ARVO Annual Meeting Abstract July 2019

Factors Predictive of Remission of Chronic Anterior Uveitis

Lucia Sobrin; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; Pichaporn Artornsombudh; Siddharth Pujari; Charles Stephen Foster; Douglas A Jabs; James T Rosenbaum; Grace Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6683. doi:

ARVO Annual Meeting Abstract July 2019

Dexamethasone Intravitreal Implantation To Treat Uveitic Macular Edema

Grace Levy-Clarke; Jeffrey Wipfli; Nandesh N. Patel; Mireya Benitez Cartaya; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3512. doi:

ARVO Annual Meeting Abstract July 2019

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

John H Kempen; Craig W Newcomb; Charles S Foster; Douglas A Jabs; Grace Levy-Clarke; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; Jeanine M Buchanich

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3854. doi:

ARVO Annual Meeting Abstract July 2019

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in presumed tubercular choroiditis

Vishali Gupta; Rupesh Vijay Agrawal; Ilaria Testi; Sarakshi Mahajan; Dhananjay Raje; Aniruddha Agarwal; Dinesh Gunasekeran; John H Kempen; Quan Dong Nguyen; Carlos Pavesio

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):860. doi:

ARVO Annual Meeting Abstract July 2019

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in intermediate uveitis and panuveitis

Ilaria Testi; Rupesh Vijay Agrawal; Sarakshi Mahajan; Dhananjay Raje; Aniruddha Agarwal; Dinesh Gunasekeran; John H Kempen; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):862. doi:

ARVO Annual Meeting Abstract July 2019

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in patients with granulomatous anterior uveitis

Aniruddha Agarwal; Rupesh Vijay Agrawal; Ilaria Testi; Sarakshi Mahajan; Dinesh Visva Gunasekeran; Dhananjay Raje; John H Kempen; Quan Dong Nguyen; Carlos Pavesio; Vishali Gupta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3528. doi:

ARVO Annual Meeting Abstract June 2017

Estimated Prevalence of Visual Impairment in Sub-Saharan Africa (2015)

John H Kempen; Rupert R A Bourne; Tien Yin Wong; Hugh Taylor; Nina Tahhan; Gretchen Stevens; Serge Resnikoff; Konrad Pesudovs; Hans Limburg; Janet L Leasher; Jill E Keeffe; Jost B Jonas; Tasanee Braithwaite; Seth Flaxman; Kovin Shunmugam Naidoo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2197. doi:

ARVO Annual Meeting Abstract June 2017

Global Prevalence of Blindness and Distance and Near Vision Impairment: Magnitude, Temporal Trends, and Projections

Rupert R A Bourne; Seth Flaxman; Tasanee Braithwaite; Jost B Jonas; Jill Keeffe; John H Kempen; Janet L Leasher; Hans Limburg; Kovin Shunmugam Naidoo; Konrad Pesudovs; Serge Resnikoff; Gretchen Stevens; Nina Tahhan; Tien Wong; Hugh Taylor

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):840. doi:

ARVO Annual Meeting Abstract June 2015

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

John H Kempen; Michael M Altaweel; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3209. doi:

ARVO Annual Meeting Abstract June 2015

Prevalence and Risk Factors of Epiretinal membrane in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Lyndell L Lim; Francis Abreu; Elizabeth A Sugar; Alyce Burke; Michael M Altaweel; P. Kumar Rao; Janet T. Holbrook; Susan G Elner; Richard Stawell; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group.

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5773. doi:

ARVO Annual Meeting Abstract June 2015

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Michael M Altaweel; John H Kempen; Lea T. Drye; Janet T. Holbrook; Douglas A Jabs; Elizabeth A Sugar; Jennifer E Thorne; Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5774. doi:

Clinical Trials May 2014

Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study

PDF

John D. Sheppard; Melissa M. Toyos; John H. Kempen; Paramjit Kaur; C. Stephen Foster
TAGS: acetates, difluprednate, prednisolone, uveitis, uveitis, anterior, surrogate endpoints, anterior chamber of eye, safety
Invest. Ophthalmol. Vis. Sci.. 2014; 55(5):2993-3002. doi: https://doi.org/10.1167/iovs.13-12660

Includes: Supplemental Content

ARVO Annual Meeting Abstract April 2014

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Elizabeth A Sugar; Janet T Holbrook; John H Kempen; Alyce E Burke; Lea T Drye; Jennifer E Thorne; Thomas A Louis; Douglas A Jabs; Michael M Altaweel; Kevin Frick; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5796. doi:

ARVO Annual Meeting Abstract April 2014

Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis

Ebenezer Daniel; Maxwell Pistilli; H Nida Sen; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum; John H Kempen; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6031. doi:

ARVO Annual Meeting Abstract April 2014

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Douglas A Jabs; Mark L Van Natta; Michael M Altaweel; James P Dunn; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; John H Kempen; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6033. doi:

ARVO Annual Meeting Abstract April 2014

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan Lightman; Jennifer E Thorne; Janet T Holbrook; The Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6036. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Risk of Non-infectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database

Incidence of Cataract in Eyes with Anterior Uveitis

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Collaborative Ocular Tuberculosis Study (COTS) consensus guidelines on initiating antitubercular therapy in presumed tubercular retinal vasculitis

Factors Predictive of Remission of Chronic Anterior Uveitis

Dexamethasone Intravitreal Implantation To Treat Uveitic Macular Edema

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in presumed tubercular choroiditis

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in intermediate uveitis and panuveitis

Collaborative Ocular Tuberculosis Study (COTS) Consensus guidelines on initiating antitubercular therapy in patients with granulomatous anterior uveitis

Estimated Prevalence of Visual Impairment in Sub-Saharan Africa (2015)

Global Prevalence of Blindness and Distance and Near Vision Impairment: Magnitude, Temporal Trends, and Projections

Benefits of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Intraocular Implant for Intermediate, Posterior and Panuveitis: 54 month results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Prevalence and Risk Factors of Epiretinal membrane in the Multicenter Uveitis Steroid Treatment (MUST) Trial

Risks and Quality of Life associated with Fluocinolone Acetonide Intraocular Implant Versus Systemic Anti-inflammatory Therapy for Intermediate, Posterior or Panuveitis: 4.5 year results of The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study

Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study

Incremental Cost-Effectiveness of Fluocinolone Acetonide Implant vs Systemic Therapy for Non-infectious Intermediate, Posterior, and Pan-Uveitis

Incidence and Risk Factors for Ocular Hypertension in Adults with Non-infectious Uveitis

Risk factors for reduced visual acuity in non-infectious intermediate, posterior, and panuveitis

Visual acuity outcome of non-infectious intermediate, posterior, and panuveitis in the Multicenter Uveitis Steroid Treatment (MUST) Trial

To View More...

You must be signed into an individual account to use this feature.